Two Sigma Securities’s AIM ImmunoTech AIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-207
Closed -$2.53K 2253
2025
Q1
$2.53K Sell
207
-507
-71% -$8.15K ﹤0.01% 1339
2024
Q4
$14.1K Buy
+714
New +$16.6K ﹤0.01% 1378
2024
Q3
Sell
-1,251
Closed -$46.6K 3859
2024
Q2
$46.6K Buy
1,251
+1,037
+485% +$44K ﹤0.01% 2579
2024
Q1
$10.1K Buy
+214
New +$8.87K ﹤0.01% 2765
2023
Q4
Sell
-607
Closed -$27.6K 3829
2023
Q3
$27.6K Buy
607
+504
+489% +$31.1K ﹤0.01% 2534
2023
Q2
$6.9K Sell
103
-63
-38% -$3.04K ﹤0.01% 2641
2023
Q1
$7.14K Buy
166
+22
+15% +$1.14K ﹤0.01% 2497
2022
Q4
$4.5K Buy
+144
New +$6.69K ﹤0.01% 2462
2022
Q3
Sell
-312
Closed -$24K 3324
2022
Q2
$24K Buy
+312
New +$29.9K ﹤0.01% 1936
2019
Q2
Sell
-2
Closed -$2K 2593
2019
Q1
$2K Sell
2
-5
-71% -$4.45K ﹤0.01% 1759
2018
Q4
$5K Buy
+7
New +$6.42K ﹤0.01% 2061
2018
Q2
Sell
-7
Closed -$11K 3238
2018
Q1
$11K Sell
7
-11
-61% -$23K ﹤0.01% 2610
2017
Q4
$28K Buy
+18
New +$25.9K ﹤0.01% 1601
2016
Q3
Hold
0
-$3K 908
2016
Q2
Hold
0
416
2016
Q1
Sell
-1
Closed -$3K 500
2015
Q4
$3K Buy
+1
New +$6.8K ﹤0.01% 258
2015
Q3
Hold
0
209

Other funds holding AIM

Two Sigma Securities's AIM Position: Q2 2025 in Review

Two Sigma Securities sold out of AIM ImmunoTech (AIM) in Q2 2025, closing a stake of 207 shares — an estimated $2.53K sold.

Two Sigma Securities first reported a position in AIM in Q4 2015 and held it in 14 quarters. The position peaked at $46.6K in Q2 2024. 12 funds tracked by Wall St. Rank hold AIM as of Q2 2025.

  • Two Sigma Securities reported no remaining AIM ImmunoTech position as of Q2 2025 after selling out during the quarter.
  • Two Sigma Securities sold 207 AIM ImmunoTech shares in Q2 2025, an estimated $2.53K.
  • Two Sigma Securities first reported a position in AIM ImmunoTech in Q4 2015 and held it in 14 quarters.
  • Two Sigma Securities's AIM ImmunoTech position peaked at $46.6K in Q2 2024.
  • 12 funds tracked by Wall St. Rank held AIM ImmunoTech as of Q2 2025.

Based on Two Sigma Securities's 13F filing for Q2 2025, filed 14 Aug 2025.